Astaxanthin Haematococcus pluvialis Flotow (source alga; accepted name in WoRMS: Haematococcus lacustris)
Also called: Haematococcus pluvialis, Haematococcus algae, astaxanthin-rich oleoresin
Astaxanthin is a xanthophyll carotenoid. In the EU, supplements use astaxanthin-rich oleoresin from the microalga Haematococcus pluvialis. In the US, astaxanthin and Haematococcus algae meal are listed color additives for salmonid fish feed.
- Category
- Marine and algae
- Forms
- Astaxanthin-rich oleoresin extracted from Haematococcus pluvialis algae
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2021 meta-analysis (Nutrients) included 9 RCTs of oral astaxanthin for skin aging. Per its study table, 6 tested astaxanthin alone, but two (Phetcharat 2015; Winther 2015 abstract) appear to report one Thai trial versus rose-hip powder, leaving 5 distinct; 2 combined it with tocotrienol or collagen. [1]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BSkin and hair1 topic
CBrain, mood and sleep1 topic
CHeart and blood vessels1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Skin aging (moisture, elasticity, wrinkles) | B | 2021 meta-analysis of 9 RCTs of oral astaxanthin: skin moisture (SMD 0.53) and elasticity (SMD 0.77) improved versus placebo; wrinkle depth did not change significantly. [1] |
| Weight, blood pressure, glucose and lipids | C | 2020 meta-analysis of 14 articles: no effect on glucose, HbA1c, total or LDL cholesterol, triglycerides, weight or blood pressure; HDL rose 1.47 mg/dL; CRP fell only with ≥12 weeks or >12 mg/day. [2] |
| Fatigue, cognition and exercise performance | C | 2024 meta-analysis of 11 RCTs (346 healthy participants): no significant effect on reaction time and a marginal effect on cognitive accuracy; combined with regular training, physical performance improved (SMD 0.62). [3] |
Main constituents: Astaxanthin (3,3′-dihydroxy-β,β-carotene-4,4′-dione) [5]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- EFSA assessed food supplements providing up to 8 mg astaxanthin per day. [4]
Upper limits
- EU: astaxanthin-rich oleoresin from Haematococcus pluvialis is authorized in food supplements for adults and adolescents aged 14 and over, at 40–80 mg/day of oleoresin, resulting in no more than 8 mg astaxanthin per day; labels must state that the supplement should not be consumed by infants, children and adolescents younger than 14 years (Implementing Regulation (EU) 2021/1377). [6]
- EFSA acceptable daily intake (ADI): 0.2 mg astaxanthin per kg body weight (set by the FEEDAP Panel in 2019). [4]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications18 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- EFSA (2020): 8 mg/day from supplements plus astaxanthin from fish and crustaceans is safe for adults; adolescents aged 14 to under 18 reach the ADI, and the ADI is exceeded by 28% in children aged 10 to under 14. [4]
Identity, quality and standardization
- US specification for Haematococcus algae meal (fish-feed color): at least 1.5% astaxanthin; no more than 5 ppm lead, 2 ppm arsenic and 1 ppm mercury. [7]
- WoRMS lists Haematococcus pluvialis Flotow, 1844 as an unaccepted name; the accepted name is Haematococcus lacustris (Girod-Chantrans) Rostafinski, 1875. [8]
Regulatory status
- US: astaxanthin (21 CFR 73.35) and Haematococcus algae meal (21 CFR 73.185) are color additives permitted in salmonid fish feed, at no more than 80 mg astaxanthin per kg of finished feed. [5]
- EU: listed in the Union list of novel foods for food supplements; the label must use the name 'Astaxanthin'. [6]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Astaxanthin (3,3'-dihydroxy-β,β-carotene-4,4'-dione) Carotenoid (a β,β-carotene derivative) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 18 entries naming Haematococcus pluvialis (one spelled 'pulvialis'), the alga used as the source of astaxanthin-rich oleoresin (earliest NDI 52 submitted 1999-03-22; most recent NDI 1384 submitted 2025-02-10). Other entries name astaxanthin from other sources, including Phaffia rhodozyma (NDI 814) and Paracoccus carotinifaciens (NDI 829, 961). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]
- FDA lists astaxanthin (21 CFR 73.35) and Haematococcus algae meal (21 CFR 73.185) as color additives permitted in salmonid fish feed, at no more than 80 mg astaxanthin per kg of finished feed; these listings concern fish feed, not dietary supplements. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P4]
- Astaxanthin content; lead, arsenic and mercury — The US color-additive specification for Haematococcus algae meal (fish feed) requires at least 1.5% astaxanthin and no more than 5 ppm lead, 2 ppm arsenic and 1 ppm mercury; it is a feed-additive standard, not a supplement standard. [P2]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- eCFR. 21 CFR 73.35 Astaxanthin (current as of October 27, 2026), 2026-10-27. ecfr.gov
- eCFR. 21 CFR 73.185 Haematococcus algae meal (current as of October 27, 2026), 2026-10-27. ecfr.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of October 23, 2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (retrieved October 29, 2026), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (list retrieved October 29, 2026), 2026-10-29. ntp.niehs.nih.gov
Sources
- Zhou X, et al. Systematic review and meta-analysis on the effects of astaxanthin on human skin aging. Nutrients 2021;13(9):2917, 2021-08-24. pubmed.ncbi.nlm.nih.gov
- Xia W, et al. The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: a meta-analysis of randomized controlled trials. Pharmacol Res 2020;161:105113, 2020-11. pubmed.ncbi.nlm.nih.gov
- Liu C, et al. Effects of astaxanthin supplementation on fatigue, motor function and cognition: a meta-analysis of randomized controlled trials. Biol Res Nurs 2024;26(3):469-480, 2024-07. pubmed.ncbi.nlm.nih.gov
- EFSA NDA Panel. Safety of astaxanthin for its use as a novel food in food supplements. EFSA J 2020;18(2):e05993, 2020-02-05. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 73.35 Astaxanthin (current as of October 27, 2026), 2026-10-27. ecfr.gov
- Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods (original text), 2017-12-20. eur-lex.europa.eu
- eCFR. 21 CFR 73.185 Haematococcus algae meal (current as of October 27, 2026), 2026-10-27. ecfr.gov
- WoRMS. Haematococcus pluvialis Flotow, 1844, AphiaID 608431 (accessed October 28, 2026). marinespecies.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in marine and algae: Bladderwrack · Carrageenan and agar · Chlorella · Dunaliella · Ecklonia cava · Fucoidan · Kelp and seaweed · Sea moss · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.